CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1989; 39:33-39
doi: 10.3322/canjclin.39.1.33
© 1989 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mettlin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mettlin, C.

CA: A Cancer Journal for Clinicians, Vol 39, 33-39, Copyright © 1989 by American Cancer Society


Trends in Years of Life Lost to Cancer: 1970 to 1985

Curtis Mettlin PhD1

1 Chief of Epidemiologic Research and Director of Cancer Control at Roswell Park Memorial Institute in Buffalo, New York.

Standardized rates of years of life lost may be a particularly useful tool in future assessments of progress in cancer control. This measure provides insight into the magnitude of the impact of changes in patterns of mortality from cancer that may not be evident from other aggregate indices. The observed trends suggest that reductions in the cancer burden in the United States have been occurring steadily over the last 15 years. This trend compares favorably with the trend for heart disease, the other leading disease cause of premature death. The reduction in years of life lost results from improvements that occur at nearly every age level but that are particularly evident among children and young adults. Variations in rates of change are evident for different diagnostic categories. Years of life lost from respiratory cancer have increased, but dramatic reductions have occurred for genital cancers, leukemias, and lymphomas. These reductions in the cancer burden in the United States may be important signs that there have been improvements in the treatment of cancer.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by American Cancer Society.